Litcius/Paper detail

Induction versus no induction chemotherapy before neoadjuvant chemoradiotherapy and surgery in oesophageal adenocarcinoma: a multicentre randomised phase II trial (NCCTG N0849 [Alliance])

Harry H. Yoon, Fang‐Shu Ou, Gamini S. Soori, Qian Shi, Dennis A. Wigle, Robert P. Sticca, Robert C. Miller, James L. Leenstra, Patrick J. Peller, Brenda Ginos, Erica N. Heying, Tsung‐Teh Wu, Timothy F. Drevyanko, Stephen Ko, Bassam Mattar, Daniel A. Nikcevich, Robert J. Behrens, Maged Khalil, George P. Kim, Steven R. Alberts

2021European Journal of Cancer21 citationsDOIOpen Access PDF

Topics & Concepts

MedicineInduction chemotherapyChemoradiotherapyChemotherapyOncologyInternal medicineAdenocarcinomaSurgeryCancerEsophageal Cancer Research and TreatmentGastric Cancer Management and OutcomesHead and Neck Cancer Studies
Induction versus no induction chemotherapy before neoadjuvant chemoradiotherapy and surgery in oesophageal adenocarcinoma: a multicentre randomised phase II trial (NCCTG N0849 [Alliance]) | Litcius